Compounds > dehydroepiandrosterone sulfate
Page last updated: 2024-08-21

dehydroepiandrosterone sulfate and Myotonia

dehydroepiandrosterone sulfate has been researched along with Myotonia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sugino, M1
Kurihara, T; Nakazora, H1
Carter, JN; Steinbeck, KS1

Other Studies

3 other study(ies) available for dehydroepiandrosterone sulfate and Myotonia

ArticleYear
Dehydroepiandrosterone sulfate (DHEAS) therapy for myotonic dystrophy type 1 and myotonia.
    Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:12

    Topics: Adult; Animals; Dehydroepiandrosterone Sulfate; Humans; Male; Mice; Myotonia; Myotonic Dystrophy; Rats; Treatment Outcome

2005
The effect of dehydroepiandrosterone sulfate (DHEAS) on myotonia: intracellular studies.
    Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:12

    Topics: Action Potentials; Animals; Dehydroepiandrosterone Sulfate; Disease Models, Animal; Electrophysiology; Isometric Contraction; Mice; Muscle, Skeletal; Myotonia; Rats; Rats, Wistar

2005
Reduced adrenal androgens in patients with myotonic dystrophy.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 60, Issue:3

    Topics: Adolescent; Adrenal Cortex; Adult; Aged; Androgens; Cosyntropin; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Hydrocortisone; Male; Middle Aged; Muscular Dystrophies; Myotonia

1985